Cargando…
The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation
Coronary heart disease (CHD) is the leading cause of death worldwide. However, current diagnostic tools for CHD, such as coronary computed tomography angiography (CCTA), are poorly suited for monitoring treatment response. Recently, we have introduced an artificial-intelligence-guided integrated gen...
Autores principales: | Philibert, Robert, Moody, Joanna, Philibert, Willem, Dogan, Meeshanthini V., Hoffman, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297911/ https://www.ncbi.nlm.nih.gov/pubmed/37372412 http://dx.doi.org/10.3390/genes14061233 |
Ejemplares similares
-
Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study
por: Dogan, Meeshanthini V., et al.
Publicado: (2018) -
Alcohol Use Intensity Decreases in Response to Successful Smoking Cessation Therapy
por: Philibert, Robert, et al.
Publicado: (2021) -
Epigenetic biomarkers for smoking cessation
por: Fang, Fang, et al.
Publicado: (2023) -
Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders
por: Andersen, Allan M., et al.
Publicado: (2015) -
A Direct Comparison of the Relationship of Epigenetic Aging and Epigenetic Substance Consumption Markers to Mortality in the Framingham Heart Study
por: Mills, James A., et al.
Publicado: (2019)